Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...
An international group of researchers led by Pompeu Fabra University has discovered the nanomachine that controls ...
ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...